Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) ...

Patients with locally advanced cervical cancer were randomized to receive either pembrolizumab or placebo in combination with ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

AstraZeneca PLC AZN shares inched down 0.40% to £119.68 Tuesday, on what proved to be an all-around great trading session for ...

Jack Last died after having the AstraZeneca Covid jab following a ‘litany’ of errors by GP services and the NHS ...

Jack Last, 27, died from a blood clot as a "direct result" from getting the Covid-19 vaccine, with an independent report ...

The AstraZeneca PLC ADR AZN inched 0.98% higher to $79.04 Monday, on what proved to be an all-around mixed trading session ...

Imfinzi is a human monoclonal antibody that targets the PD-L1 protein, whereas Imjudo focuses on the CTLA-4 protein.

AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...

New biologics such as GSK's Benlysta and AstraZeneca's Saphnelo, along with off-label drugs, have been the mainstay for ...

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...